Mesoblast Limited (MESO)
(Delayed Data from NSDQ)
$6.85 USD
+0.44 (6.86%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $6.86 +0.01 (0.15%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth F Momentum F VGM
Cash flow Statements
Fiscal Year End for Mesoblast Limited falls in the month of June.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 6/30/2023 | 6/30/2022 | 6/30/2021 | 6/30/2020 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -87.96 | -81.89 | -91.35 | -98.81 | -77.94 |
Depreciation/Amortization & Depletion | 4.67 | 4.11 | 4.38 | 4.26 | 3.67 |
Net Change from Assets/Liabilities | -2.63 | -2.47 | 4.87 | -8.42 | 13.29 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 37.46 | 16.99 | 16.32 | -3.72 | 4.62 |
Net Cash From Operating Activities | -48.46 | -63.27 | -65.78 | -106.68 | -56.37 |
Property & Equipment | -0.27 | -0.26 | -0.16 | -1.65 | -2.10 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.17 | 0.07 | -0.08 | 0.00 | -1.18 |
Net Cash from Investing Activities | -0.10 | -0.19 | -0.23 | -1.65 | -3.27 |
Uses of Funds
6/30/2024 | 6/30/2023 | 6/30/2022 | 6/30/2021 | 6/30/2020 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 65.41 | 88.64 | 8.29 | 119.24 | 144.95 |
Issuance (Repayment) of Debt | -10.00 | 0.00 | -3.54 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | -3.52 | -2.66 | -2.79 | -2.93 | -1.63 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -11.63 | -11.48 | -11.83 | -1.84 | -6.28 |
Net Cash from Financing Activities | 40.25 | 74.50 | -9.87 | 114.47 | 137.04 |
Effect of Exchange Rate Changes | -0.06 | -0.17 | -0.55 | 1.42 | 1.50 |
Net Change In Cash & Equivalents | -8.36 | 10.87 | -76.43 | 7.55 | 78.90 |
Cash at Beginning of Period | 71.32 | 60.45 | 136.88 | 129.33 | 50.43 |
Cash at End of Period | 62.96 | 71.32 | 60.45 | 136.88 | 129.33 |
Diluted Net EPS | -0.89 | -1.11 | -1.41 | -1.63 | -1.47 |
Fiscal Year End for Mesoblast Limited falls in the month of June.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -87.96 | NA | NA | NA | -81.89 |
Depreciation/Amortization & Depletion | 4.67 | NA | NA | NA | 4.11 |
Net Change from Assets/Liabilities | -2.63 | NA | -34.00 | NA | -2.47 |
Net Cash from Discontinued Operations | 0.00 | NA | NA | NA | 0.00 |
Other Operating Activities | 37.46 | NA | 7.42 | NA | 16.99 |
Net Cash From Operating Activities | -48.46 | NA | -26.57 | NA | -63.27 |
Property & Equipment | -0.27 | NA | -0.19 | NA | -0.26 |
Acquisition/ Disposition of Subsidiaries | 0.00 | NA | NA | NA | 0.00 |
Investments | 0.00 | NA | NA | NA | 0.00 |
Other Investing Activities | 0.17 | NA | 0.11 | NA | 0.07 |
Net Cash from Investing Activities | -0.10 | NA | -0.09 | NA | -0.19 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 65.41 | NA | 39.71 | NA | 88.64 |
Issuance (Repayment) of Debt | -10.00 | NA | NA | NA | 0.00 |
Increase (Decrease) Short-Term Debt | -3.52 | NA | -2.15 | NA | -2.66 |
Payment of Dividends & Other Distributions | 0.00 | NA | NA | NA | 0.00 |
Other Financing Activities | -11.63 | NA | -5.96 | NA | -11.48 |
Net Cash from Financing Activities | 40.25 | NA | 31.60 | NA | 74.50 |
Effect of Exchange Rate Changes | -0.06 | NA | 1.30 | NA | -0.17 |
Net Change In Cash & Equivalents | -8.36 | NA | 6.24 | NA | 10.87 |
Cash at Beginning of Period | 71.32 | NA | 71.32 | NA | 60.45 |
Cash at End of Period | 62.96 | NA | 77.55 | NA | 71.32 |
Diluted Net EPS | NA | NA | NA | NA | -0.28 |